(Q45221750)

11 December 2017

title

Posaconazole pharmacokinetics, safety, and tolerability in subjects with varying degrees of chronic renal disease (English)

1 reference

11 December 2017

1 reference

R Courtney

1

1 reference

11 December 2017

A Sansone

2

1 reference

11 December 2017

W Smith

3

1 reference

11 December 2017

T Marbury

4

1 reference

11 December 2017

P Statkevich

5

1 reference

11 December 2017

M Martinho

6

1 reference

11 December 2017

M Laughlin

7

1 reference

11 December 2017

S Swan

8

1 reference

11 December 2017

publication date

1 February 2005

1 reference

The Journal of Clinical Pharmacology

11 December 2017

published in

1 reference

11 December 2017

volume

45

1 reference

11 December 2017

issue

2

1 reference

11 December 2017

page(s)

185-192

1 reference

A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271402

In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271402

Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance P

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271402

In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271402

Systemic fungal infections after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271402

Fungal infections in solid-organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271402

Infections due to resistant Candida species in patients with cancer who are receiving chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271402

Antifungal use in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271402

Amphotericin B nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271402

Disposition of posaconazole following single-dose oral administration in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271402

Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271402

Review of the safety and efficacy of voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271402

Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271402

21 January 2018

Identifiers

DOI

10.1177/0091270004271402

1 reference

11 December 2017

1 reference